One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Dementia diagnosis in the anti-amyloid era
doi : 10.1016/S1474-4422(24)00041-3
Volume 23, Issue 3, March 2024, Page 219
Laquinimod, Huntington's disease, and disease modification
Tiago A Mestre
doi : 10.1016/S1474-4422(24)00001-2
Volume 23, Issue 3, March 2024, Pages 220-221
Sleep matters in anti-LGI1 encephalitis
Anna Heidbreder
doi : 10.1016/S1474-4422(24)00029-2
Volume 23, Issue 3, March 2024, Pages 221-223
PROMISE of low-cost immunosuppressants for myasthenia gravis
*Sithara Ramdas, Jacqueline Palace
doi : 10.1016/S1474-4422(24)00034-6
Volume 23, Issue 3, March 2024, Pages 223-225
For a dementia diagnosis, clinical acumen must precede biomarkers
David S Knopman
doi : 10.1016/S1474-4422(24)00021-8
Volume 23, Issue 3, March 2024, Pages 225-226
A future treatment horizon for migraine?
Debbie L Hay
doi : 10.1016/S1474-4422(24)00032-2
Volume 23, Issue 3, March 2024, Pages 226-227
Sharing the peer review load
Laura Hart
doi : 10.1016/S1474-4422(24)00042-5
Volume 23, Issue 3, March 2024, Page 228
Thank you to The Lancet Neurology's peer reviewers in 2023
doi : 10.1016/S1474-4422(24)00047-4
Volume 23, Issue 3, March 2024, Pages e3-e6
The predictive value and clinical use of the neurological pupillary index
Michael TC Poon, Ahmed Nouby, Paul M Brennan
doi : 10.1016/S1474-4422(23)00471-4
Volume 23, Issue 3, March 2024, Page 229
The predictive value and clinical use of the neurological pupillary index – Authors' reply
Michael TC Poon, Ahmed Nouby, Paul M Brennan
doi : 10.1016/S1474-4422(23)00504-5
Volume 23, Issue 3, March 2024, Pages 229-230
Monitoring patients with severe traumatic brain injury
Randall M Chesnut, Robert H Bonow, Walter Videtta
doi : 10.1016/S1474-4422(24)00024-3
Volume 23, Issue 3, March 2024, Page 230
Monitoring patients with severe traumatic brain injury
Ramon Diaz-Arrastia, Francis Bernard, Lori Shutter, William Barsan, Robert Silbergleit
doi : 10.1016/S1474-4422(24)00023-1
Volume 23, Issue 3, March 2024, Pages 230-231
Monitoring patients with severe traumatic brain injury
Nathan Beucler
doi : 10.1016/S1474-4422(24)00004-8
Volume 23, Issue 3, March 2024, Pages 231-232
Monitoring patients with severe traumatic brain injury
*Nicolas Engrand, Loïc Miry
doi : 10.1016/S1474-4422(24)00022-X
Volume 23, Issue 3, March 2024, Page 232
Monitoring patients with severe traumatic brain injury – Authors' reply
Jean-Francois Payen, Tobias Gauss, Antoine Vilotitch, Pierre Bouzat
doi : 10.1016/S1474-4422(24)00030-9
Volume 23, Issue 3, March 2024, Pages 232-233
Brain capital is crucial for global sustainable development
Harris A Eyre, William Hynes, Rym Ayadi, Facundo Manes, Pawel Swieboda
doi : 10.1016/S1474-4422(24)00031-0
Volume 23, Issue 3, March 2024, Pages 233-235
Correction to Lancet Neurol 2024; 23: 133–34
doi : 10.1016/S1474-4422(24)00049-8
Volume 23, Issue 3, March 2024, Page e7
Correction to Lancet Neurol 2024; 23: 191–204
doi : 10.1016/S1474-4422(24)00048-6
Volume 23, Issue 3, March 2024, Page e7
Correction to Lancet Neurol 2024; 23: 205–18
doi : 10.1016/S1474-4422(24)00050-4
Volume 23, Issue 3, March 2024, Page e7
Karen Duff: blazing a path in dementia research
Priya Venkatesan
doi : 10.1016/S1474-4422(23)00473-8
Volume 23, Issue 3, March 2024, Page 236
Biomedical research must change as the climate does
Grace Lindsay
doi : 10.1016/S1474-4422(24)00035-8
Volume 23, Issue 3, March 2024, Page 237
The postmenopausal brain: no silver bullet, but silver linings
Riley Bove, Hannah Silverman, Claudia Valeggia
doi : 10.1016/S1474-4422(24)00043-7
Volume 23, Issue 3, March 2024, Pages 238-239
The source of imagination
Robert Stirrups
doi : 10.1016/S1474-4422(24)00044-9
Volume 23, Issue 3, March 2024, Page 240
The synergy of neurology and music
Jules Morgan
doi : 10.1016/S1474-4422(24)00045-0
Volume 23, Issue 3, March 2024, Page 241
The cultural history of dementia
Hollie Sherwood-Martin
doi : 10.1016/S1474-4422(24)00046-2
Volume 23, Issue 3, March 2024, Page 241
An influential discovery
Christopher Walsh
doi : 10.1016/S1474-4422(23)00468-4
Volume 23, Issue 3, March 2024, Page 242
Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
Ralf Reilmann, Karen E Anderson, Andrew Feigin, Sarah J Tabrizi, Blair R Leavitt, Julie C Stout, Paola Piccini, Robin Schubert, Pippa Loupe, Anna Wickenberg*, Beth Borowsky*, Gail Rynkowski, Rita Volkinshtein, Thomas Li, Juha-Matti Savola*, Michael Hayden*, Mark Forrest Gordon, on behalf of the LEGATO-HD Study Groupâ€
doi : 10.1016/S1474-4422(23)00454-4
Volume 23, Issue 3, March 2024, Pages 243-255
Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study
Amaia Mu?oz-Lopetegi*, Mar Guasp*, Laia Prades, Eugenia Mart?nez-Hern?ndez, Mireia Rosa-Just?cia, V?ctor Patricio, Tha?s Armangué, Lorena Rami, Roger Borrà s, Josefina Castro-Fornieles, Albert Compte, Carles Gaig, Joan Santamaria†, Josep Dalmau†, on behalf of the Spanish anti-LGI1 Encephalitis Study Group
doi : 10.1016/S1474-4422(23)00463-5
Volume 23, Issue 3, March 2024, Pages 256-266
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study
Pushpa Narayanaswami*, Donald B Sanders*, Laine Thomas, Dylan Thibault, Jason Blevins, Rishi Desai, Andrew Krueger, Kathie Bibeau, Bo Liu, Jeffrey T Guptill, on behalf of the PROMISE-MG Study Group
doi : 10.1016/S1474-4422(24)00028-0
Volume 23, Issue 3, March 2024, Pages 267-276
Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges
Jeremy Chataway, Thomas Williams, Vivien Li, Ruth Ann Marrie, Daniel Ontaneda, Robert J Fox
doi : 10.1016/S1474-4422(24)00027-9
Volume 23, Issue 3, March 2024, Pages 277-301
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
Giovanni B Frisoni, Cristina Festari, Federico Massa, Matteo Cotta Ramusino, Stefania Orini, Dag Aarsland, Federica Agosta, Claudio Babiloni, Barbara Borroni, Stefano F Cappa, Kristian S Frederiksen, Lutz Froelich, Valentina Garibotto, Alexander Haliassos, Frank Jessen, Anita Kamondi, Roy PC Kessels, Silvia D Morbelli, John T O’Brien, Markus Otto, Armand Perret-Liaudet, Francesca B Pizzini, Mathieu Vandenbulcke, Ritva Vanninen, Frans Verhey, Meike W Vernooij, Tarek Yousry, Mercè Boada Rovira, Bruno Dubois, Jean Georges, Oskar Hansson, Craig W Ritchie, Philip Scheltens, Wiesje M van der Flier, Flavio Nobili
doi : 10.1016/S1474-4422(23)00447-7
Volume 23, Issue 3, March 2024, Pages 302-312
Potential treatment targets for migraine: emerging options and future prospects
Chia-Chun Chiang, Frank Porreca, Carrie E Robertson, David W Dodick
doi : 10.1016/S1474-4422(24)00003-6
Volume 23, Issue 3, March 2024, Pages 313-324
